免疫蛍光測定アッセイの世界市場予測(~2023年):試薬、一次抗体、二次抗体、キット、画像装置、顕微鏡

MarketsandMarketsが発行した調査報告書(BT-6044)
◆英語タイトル:Immunofluorescence Assay Market by Product (Reagent, Primary & Secondary Antibody, Kit, Imaging Equipment, Immunofluorescence Microscopy), Type (Direct, Indirect), Disease (Cancer, Cardiovascular, Infectious Disease) & End User - Global Forecast to 2023
◆商品コード:BT-6044
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2018年2月28日
◆ページ数:194
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオ技術
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。

MarketsandMarketsが発行した当調査レポートでは、免疫蛍光測定アッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別分析、種類別分析、疾患別分析、需要先別分析、免疫蛍光測定アッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

・イントロダクション
・エグゼクティブサマリー
・免疫蛍光測定アッセイの世界市場:市場インサイト
・免疫蛍光測定アッセイの世界市場:市場概観/市場動向
・免疫蛍光測定アッセイの世界市場:市場シェア分析
・免疫蛍光測定アッセイの世界市場:製品別分析/市場規模
・免疫蛍光測定アッセイの世界市場:種類別分析/市場規模
・免疫蛍光測定アッセイの世界市場:疾患別分析/市場規模
・免疫蛍光測定アッセイの世界市場:需要先別分析/市場規模
・免疫蛍光測定アッセイのアジア市場規模予測
・免疫蛍光測定アッセイのヨーロッパ市場規模予測
・免疫蛍光測定アッセイのアメリカ市場規模予測
・免疫蛍光測定アッセイの世界市場動向
・免疫蛍光測定アッセイの世界市場:競争状況
・免疫蛍光測定アッセイの世界市場:関連企業分析
...

※上記の和訳は最新内容ではない場合があります。
【レポートの概要】

The global immunofluorescence assay market is projected to reach USD 2.01 Billion by 2023 from USD 1.51 Billion in 2018, at a CAGR of 5.8%. The increasing prevalence of chronic diseases, increasing R&D spending, and increasing healthcare spending are the major factors driving the growth of the immunofluorescence assay market.
The report analyzes the global immunofluorescence assay market by product, type, disease, end user, and region. On the basis of product, the reagents segment accounted for the largest share of the global immunofluorescence assay market in 2017. The growing applications of biosciences and biotechnology within the pharmaceutical and healthcare fields, the rising prevalence of a number of diseases, growing R&D activities, and government initiatives to strengthen national research capabilities are the factors attributing for the largest share of the reagents segment.

Based on type, the global immunofluorescence assay market is segmented into indirect and direct immunofluorescence. In 2017, the indirect immunofluorescence accounted for the largest share of the market. The advantages of this technique, such as its sensitivity, flexibility, better amplification of the signal, and lower cost over direct immunofluorescence is the key factor increasing the adoption of this technique.

On the basis of disease, the infectious diseases segment accounted for the largest share of the global immunofluorescence assay market in 2017. The large share of this segment is attributed to the increasing prevalence of infectious diseases across the globe and the widespread adoption of immunofluorescence techniques for the study and diagnosis of infectious diseases.

Based on end user, the pharmaceutical and biotechnology companies accounted for the largest share of the global immunofluorescence assay market. Factors such as the increasing use of immunofluorescence assay in the study of various diseases in drug discovery and development processes in these companies contributes for the growth of this end user segment.

Geographically, the global immunofluorescence assay market is segmented into North America, Europe, Asia Pacific, and Rest of the World. In 2017, North America accounted for the largest share of the immunofluorescence assay market, followed by Europe and Asia Pacific. The rising incidence of chronic diseases, increasing R&D spending, increasing research activities, favorable government funding opportunities, and the presence of key players in this region are the major factors driving the growth of the immunofluorescence assay market in North America.

Immunofluorescence Assay Market

High cost of immunofluorescence instruments and implementation of excise duty by the US government are the factors restraining the growth of the global immunofluorescence assay market.

The prominent players in the global immunofluorescence assay market are Thermo Fisher (US), Inova Diagnostics (US), Bio-Rad (US), Abcam (UK), PerkinELmer (US), Merck Millipore (US), Cell Signaling Technology (US), MEDIPAN GMBH (Germany), Sino Biological (China), Danaher (US), and Vector Laboratories (US).

【レポートの目次】

1 Introduction (Page No. – 18)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.3.3 Currency
1.4 Stakeholders

2 Research Methodology (Page No. – 21)
2.1 Research Approach
2.1.1 Secondary Sources
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Sources
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 29)

4 Premium Insights (Page No. – 33)
4.1 Immunofluorescence Assay: Market Overview
4.2 Immunofluorescence Assay Market: Developed vs Developing Countries
4.3 Geographic Snapshot: Immunofluorescence Assay Market (2017)
4.4 Geographic Mix: Immunofluorescence Assay Market
4.5 Immunofluorescence Assay Market, By Product

5 Market Overview (Page No. – 36)
5.1 Introduction
5.2 Key Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Increasing Prevalence of Chronic Diseases
5.2.1.2 Increasing R&D Spending
5.2.1.3 Increasing Healthcare Spending
5.2.2 Market Restraints
5.2.2.1 High Cost of Instruments
5.2.2.2 Implementation of Excise Duty By the US Government
5.2.3 Market Opportunities
5.2.3.1 High Growth Opportunities in Emerging Markets
5.2.4 Market Challenges
5.2.4.1 Quality Concerns Over Research Antibodies

6 Immunofluorescence Assay Market, By Product (Page No. – 42)
6.1 Introduction
6.2 Reagents
6.2.1 Stains & Dyes
6.2.2 Media & Sera
6.2.3 Fixatives
6.2.4 Buffers
6.2.5 Probes
6.2.6 Solvents
6.2.7 Other Reagents
6.3 Instruments
6.3.1 Microscopes
6.3.2 Imaging Analysis Systems
6.4 Antibodies
6.4.1 Primary Antibodies
6.4.2 Secondary Antibodies
6.5 Kits
6.6 Consumables & Accessories

7 Immunofluorescence Assay Market, By Type (Page No. – 62)
7.1 Introduction
7.2 Indirect Immunofluorescence
7.3 Direct Immunofluorescence

8 Immunofluorescence Assay Market, By Disease (Page No. – 67)
8.1 Introduction
8.2 Cancer
8.3 Infectious Diseases
8.4 Cardiovascular Diseases
8.5 Autoimmune Diseases
8.6 Other Diseases

9 Immunofluorescence Assay Market, By End User (Page No. – 75)
9.1 Introduction
9.2 Pharmaceutical & Biotechnology Companies
9.3 Academic & Research Institutes
9.4 Hospitals & Diagnostic Centers
9.5 Contract Research Organizations

10 Immunofluorescence Assay Market, By Region (Page No. – 81)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Rest of Asia Pacific
10.5 Latin America
10.6 Middle East and Africa

11 Competitive Landscape (Page No. – 138)
11.1 Introduction
11.2 Market Leadership Analysis
11.3 Geographic Revenue Mix of the Major Players
11.4 Competitive Scenario
11.4.1 Product Launches
11.4.2 Expansions
11.4.3 Acquisitions
11.4.4 Agreements and Partnerships
11.4.5 Announcements

12 Company Profiles (Page No. – 144)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
12.1 Thermo Fisher Scientific Inc.
12.2 Abcam PLC
12.3 Bio-Rad Laboratories, Inc.
12.4 Perkinelmer Inc.
12.5 Merck Millipore
12.6 Inova Diagnostics (A Part of Werfern Company)
12.7 Cell Signaling Technology, Inc.
12.8 Medipan GmbH
12.9 Sino Biological Inc.
12.10 Danaher Corporation
12.11 Vector Laboratories (A Part of Maravai Lifesciences)

*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 183)
13.1 Discussion Guide
13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.3 Introducing RT: Real-Time Market Intelligence
13.4 Available Customizations
13.5 Related Reports
13.6 Author Details

List of Tables (165 Tables)

Table 1 Immunofluorescence Assay Market, By Product, 2016–2023 (USD Million)
Table 2 Immunofluorescence Reagents Market, By Type, 2016–2023 (USD Million)
Table 3 Immunofluorescence Reagents Market, By Country, 2016–2023 (USD Million)
Table 4 Immunofluorescence Stains & Dyes Market, By Country, 2016–2023 (USD Million)
Table 5 Immunofluorescence Media & Sera Market, By Country, 2016–2023 (USD Million)
Table 6 Immunofluorescence Fixatives Market, By Country, 2016–2023 (USD Million)
Table 7 Immunofluorescence Buffers Market, By Country, 2016–2023 (USD Million)
Table 8 Immunofluorescence Probes Market, By Country, 2016–2023 (USD Million)
Table 9 Immunofluorescence Solvents Market, By Country, 2016–2023 (USD Million)
Table 10 Other Immunofluorescence Reagents Market, By Country, 2016–2023 (USD Million)
Table 11 Immunofluorescence Instruments Market, By Type, 2016–2023 (USD Million)
Table 12 Immunofluorescence Instruments Market, By Country, 2016–2023 (USD Million)
Table 13 Immunofluorescence Microscopes Market, By Country, 2016–2023 (USD Million)
Table 14 Immunofluorescence Imaging Analysis Systems Market, By Country, 2016–2023 (USD Million)
Table 15 Immunofluorescence Antibodies Market, By Type, 2016–2023 (USD Million)
Table 16 Immunofluorescence Antibodies Market, By Country, 2016–2023 (USD Million)
Table 17 Primary Immunofluorescence Antibodies Market, By Country, 2016–2023 (USD Million)
Table 18 Secondary Immunofluorescence Antibodies Market, By Country, 2016–2023 (USD Million)
Table 19 Immunofluorescence Kits Market, By Country, 2016–2023 (USD Million)
Table 20 Immunofluorescence Consumables & Accessories Market, By Country, 2016–2023 (USD Million)
Table 21 Global Immunofluorescence Assay Market, By Type, 2016–2023 (USD Million)
Table 22 Comparison Between Direct and Indirect Immunofluorescence Techniques
Table 23 Global Indirect Immunofluorescence Assay Market, By Region/Country, 2016–2023 (USD Million)
Table 24 Global Direct Immunofluorescence Assay Market, By Country, 2016–2023 (USD Million)
Table 25 Immunofluorescence Assay Market, By Disease, 2016–2023 (USD Million)
Table 26 Immunofluorescence Assay Market for Cancer, By Country, 2016–2023 (USD Million)
Table 27 Immunofluorescence Assay Market for Infectious Diseases, By Country, 2016–2023 (USD Million)
Table 28 Immunofluorescence Assay Market for Cardiovascular Diseases, By Country, 2016–2023 (USD Million)
Table 29 Immunofluorescence Assay Market for Autoimmune Diseases, By Country, 2016–2023 (USD Million)
Table 30 Immunofluorescence Assay Market for Other Diseases, By Country, 2016–2023 (USD Million)
Table 31 Immunofluorescence Assay Market, By End User, 2016–2023 (USD Million)
Table 32 Immunofluorescence Assay Market for Pharmaceutical & Biotechnology Companies, By Country/Region, 2016–2023 (USD Million)
Table 33 Market for Academic & Research Institutes, By Country/Region, 2016–2023 (USD Million)
Table 34 Market for Hospitals & Diagnostic Centers, By Country/Region, 2016–2023 (USD Million)
Table 35 Market for Contract Research Organizations, By Country/Region, 2016–2023 (USD Million)
Table 36 Market, By Region, 2016–2023 (USD Million)
Table 37 North America: Immunofluorescence Assay Market, By Country, 2016–2023 (USD Million)
Table 38 North America: Market, By Product, 2016–2023 (USD Million)
Table 39 North America: Immunofluorescence Reagents Market, By Type, 2016–2023 (USD Million)
Table 40 North America: Immunofluorescence Instruments Market, By Type, 2016–2023 (USD Million)
Table 41 North America: Immunofluorescence Antibodies Market, By Type, 2016–2023 (USD Million)
Table 42 North America: Market, By Type, 2016–2023 (USD Million)
Table 43 North America: Market, By Disease, 2016–2023 (USD Million)
Table 44 North America: Market, By End User, 2016–2023 (USD Million)
Table 45 US: Immunofluorescence Assay Market, By Product, 2016–2023 (USD Million)
Table 46 US: Immunofluorescence Reagents Market, By Type, 2016–2023 (USD Million)
Table 47 US: Immunofluorescence Instruments Market, By Type, 2016–2023 (USD Million)
Table 48 US: Immunofluorescence Antibodies Market, By Type, 2016–2023 (USD Million)
Table 49 US: Market, By Type, 2016–2023 (USD Million)
Table 50 US: Market, By Disease, 2016–2023 (USD Million)
Table 51 US: Market, By End User, 2016–2023 (USD Million)
Table 52 Canada: Immunofluorescence Assay Market, By Product, 2016–2023 (USD Million)
Table 53 Canada: Immunofluorescence Reagents Market, By Type, 2016–2023 (USD Million)
Table 54 Canada: Immunofluorescence Instruments Market, By Type, 2016–2023 (USD Million)
Table 55 Canada: Immunofluorescence Antibodies Market, By Type, 2016–2023 (USD Million)
Table 56 Canada: Immunofluorescence Assay Market, By Type, 2016–2023 (USD Million)
Table 57 Canada: Immunofluorescence Assay Market, By Disease, 2016–2023 (USD Million)
Table 58 Canada: Immunofluorescence Assay Market, By End User, 2016–2023 (USD Million)
Table 59 Europe: Immunofluorescence Assay Market, By Country, 2016–2023 (USD Million)
Table 60 Europe: Market, By Product, 2016–2023 (USD Million)
Table 61 Europe: Immunofluorescence Reagents Market, By Type, 2016–2023 (USD Million)
Table 62 Europe: Immunofluorescence Instruments Market, By Type, 2016–2023 (USD Million)
Table 63 Europe: Immunofluorescence Antibodies Market, By Type, 2016–2023 (USD Million)
Table 64 Europe: Market, By Type, 2016–2023 (USD Million)
Table 65 Europe: Market, By Disease, 2016–2023 (USD Million)
Table 66 Europe: Market, By End User, 2016–2023 (USD Million)
Table 67 Germany: Immunofluorescence Assay Market, By Product, 2016–2023 (USD Million)
Table 68 Germany: Immunofluorescence Reagents Market, By Type, 2016–2023 (USD Million)
Table 69 Germany: Immunofluorescence Instruments Market, By Type, 2016–2023 (USD Million)
Table 70 Germany: Immunofluorescence Antibodies Market, By Type, 2016–2023 (USD Million)
Table 71 Germany: Immunofluorescence Assay Market, By Type, 2016–2023 (USD Million)
Table 72 Germany: Market, By Disease, 2016–2023 (USD Million)
Table 73 Germany: Market, By End User, 2016–2023 (USD Million)
Table 74 UK: Immunofluorescence Assay Market, By Product, 2016–2023 (USD Million)
Table 75 UK: Immunofluorescence Reagents Market, By Type, 2016–2023 (USD Million)
Table 76 UK: Immunofluorescence Instruments Market, By Type, 2016–2023 (USD Million)
Table 77 UK: Immunofluorescence Antibodies Market, By Type, 2016–2023 (USD Million)
Table 78 UK: Market, By Type, 2016–2023 (USD Million)
Table 79 UK: Market, By Disease, 2016–2023 (USD Million)
Table 80 UK: Market, By End User, 2016–2023 (USD Million)
Table 81 France: Immunofluorescence Assay Market, By Product, 2016–2023 (USD Million)
Table 82 France: Immunofluorescence Reagents Market, By Type, 2016–2023 (USD Million)
Table 83 France: Immunofluorescence Instruments Market, By Type, 2016–2023 (USD Million)
Table 84 France: Immunofluorescence Antibodies Market, By Type, 2016–2023 (USD Million)
Table 85 France: Market, By Type, 2016–2023 (USD Million)
Table 86 France: Market, By Disease, 2016–2023 (USD Million)
Table 87 France: Market, By End User, 2016–2023 (USD Million)
Table 88 Italy: Immunofluorescence Assay Market, By Product, 2016–2023 (USD Million)
Table 89 Italy: Immunofluorescence Reagents Market, By Type, 2016–2023 (USD Million)
Table 90 Italy: Immunofluorescence Instruments Market, By Type, 2016–2023 (USD Million)
Table 91 Italy: Immunofluorescence Antibodies Market, By Type, 2016–2023 (USD Million)
Table 92 Italy: Market, By Type, 2016–2023 (USD Million)
Table 93 Italy: Market, By Disease, 2016–2023 (USD Million)
Table 94 Italy: Market, By End User, 2016–2023 (USD Million)
Table 95 Spain: Immunofluorescence Assay Market, By Product, 2016–2023 (USD Million)
Table 96 Spain: Immunofluorescence Reagents Market, By Type, 2016–2023 (USD Million)
Table 97 Spain: Immunofluorescence Instruments Market, By Type, 2016–2023 (USD Million)
Table 98 Spain: Immunofluorescence Antibodies Market, By Type, 2016–2023 (USD Million)
Table 99 Spain: Immunofluorescence Assay Market, By Type, 2016–2023 (USD Million)
Table 100 Spain: Market, By Disease, 2016–2023 (USD Million)
Table 101 Spain: Market, By End User, 2016–2023 (USD Million)
Table 102 RoE: Immunofluorescence Assay Market, By Product, 2016–2023 (USD Million)
Table 103 RoE: Immunofluorescence Reagents Market, By Type, 2016–2023 (USD Million)
Table 104 RoE: Immunofluorescence Instruments Market, By Type, 2016–2023 (USD Million)
Table 105 RoE: Immunofluorescence Antibodies Market, By Type, 2016–2023 (USD Million)
Table 106 RoE: Market, By Type, 2016–2023 (USD Million)
Table 107 RoE: Market, By Disease, 2016–2023 (USD Million)
Table 108 RoE: Market, By End User, 2016–2023 (USD Million)
Table 109 APAC: Market, By Country, 2016–2023 (USD Million)
Table 110 APAC: Market, By Product, 2016–2023 (USD Million)
Table 111 APAC: Immunofluorescence Reagents Market, By Type, 2016–2023 (USD Million)
Table 112 APAC: Immunofluorescence Instruments Market, By Type, 2016–2023 (USD Million)
Table 113 APAC: Immunofluorescence Antibodies Market, By Type, 2016–2023 (USD Million)
Table 114 APAC: Immunofluorescence Assay Market, By Type, 2016–2023 (USD Million)
Table 115 APAC: Market, By Disease, 2016–2023 (USD Million)
Table 116 APAC: Immunofluorescence Assay Market, By End User, 2016–2023 (USD Million)
Table 117 Japan: Immunofluorescence Assay Market, By Product, 2016–2023 (USD Million)
Table 118 Japan: Immunofluorescence Reagents Market, By Type, 2016–2023 (USD Million)
Table 119 Japan: Immunofluorescence Instruments Market, By Type, 2016–2023 (USD Million)
Table 120 Japan: Immunofluorescence Antibodies Market, By Type, 2016–2023 (USD Million)
Table 121 Japan: Market, By Type, 2016–2023 (USD Million)
Table 122 Japan: Market, By Disease, 2016–2023 (USD Million)
Table 123 Japan: Market, By End User, 2016–2023 (USD Million)
Table 124 China: Immunofluorescence Assay Market, By Product, 2016–2023 (USD Million)
Table 125 China: Immunofluorescence Reagents Market, By Type, 2016–2023 (USD Million)
Table 126 China: Immunofluorescence Instruments Market, By Type, 2016–2023 (USD Million)
Table 127 China: Immunofluorescence Antibodies Market, By Type, 2016–2023 (USD Million)
Table 128 China: Immunofluorescence Assay Market, By Type, 2016–2023 (USD Million)
Table 129 China: Market, By Disease, 2016–2023 (USD Million)
Table 130 China: Market, By End User, 2016–2023 (USD Million)
Table 131 India: Market, By Product, 2016–2023 (USD Million)
Table 132 India: Immunofluorescence Reagents Market, By Type, 2016–2023 (USD Million)
Table 133 India: Immunofluorescence Instruments Market, By Type, 2016–2023 (USD Million)
Table 134 India: Immunofluorescence Antibodies Market, By Type, 2016–2023 (USD Million)
Table 135 India: Immunofluorescence Assay Market, By Type, 2016–2023 (USD Million)
Table 136 India: Market, By Disease, 2016–2023 (USD Million)
Table 137 India: Market, By End User, 2016–2023 (USD Million)
Table 138 RoAPAC: Immunofluorescence Assay Market, By Product, 2016–2023 (USD Million)
Table 139 RoAPAC: Immunofluorescence Reagents Market, By Type, 2016–2023 (USD Million)
Table 140 RoAPAC: Immunofluorescence Instruments Market, By Type, 2016–2023 (USD Million)
Table 141 RoAPAC: Immunofluorescence Antibodies Market, By Type, 2016–2023 (USD Million)
Table 142 RoAPAC: Immunofluorescence Assay Market, By Type, 2016–2023 (USD Million)
Table 143 RoAPAC: Market, By Disease, 2016–2023 (USD Million)
Table 144 RoAPAC: Immunofluorescence Assay Market, By End User, 2016–2023 (USD Million)
Table 145 Latin America: Immunofluorescence Assay Market, By Product, 2016–2023 (USD Million)
Table 146 Latin America: Immunofluorescence Reagents Market, By Type, 2016–2023 (USD Million)
Table 147 Latin America: Immunofluorescence Instruments Market, By Type, 2016–2023 (USD Million)
Table 148 Latin America: Immunofluorescence Antibodies Market, By Type, 2016–2023 (USD Million)
Table 149 Latin America: Market, By Type, 2016–2023 (USD Million)
Table 150 Latin America: Market, By Disease, 2016–2023 (USD Million)
Table 151 Latin America: Market, By End User, 2016–2023 (USD Million)
Table 152 MEA: Immunofluorescence Assay Market, By Product, 2016–2023 (USD Million)
Table 153 MEA: Immunofluorescence Reagents Market, By Type, 2016–2023 (USD Million)
Table 154 MEA: Immunofluorescence Instruments Market, By Type, 2016–2023 (USD Million)
Table 155 MEA: Immunofluorescence Antibodies Market, By Type, 2016–2023 (USD Million)
Table 156 MEA: Immunofluorescence Assay Market, By Type, 2016–2023 (USD Million)
Table 157 MEA: Immunofluorescence Assay Market, By Disease, 2016–2023 (USD Million)
Table 158 MEA: Immunofluorescence Assay Market, By End User, 2016–2023 (USD Million)
Table 159 Immunofluorescence Reagents, Antibodies, and Kits Market: Company Ranking (2017)
Table 160 Growth Strategy Matrix (2013–2017)
Table 161 Product Launches, 2013–2017
Table 162 Expansions, 2013-2017
Table 163 Acquisitions, 2013–2017
Table 164 Agreements and Partnerships, 2013–2017
Table 165 Announcements, 2013–2017

List of Figures (34 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Market, By Product, 2018 vs 2023 (USD Billion)
Figure 7 Market, By Disease, 2018 vs 2023 (USD Billion)
Figure 8 Market, By Type, 2018 vs 2023 (USD Billion)
Figure 9 Market, By End User, 2018 vs 2023 (USD Billion)
Figure 10 Geographic Snapshot: Immunofluorescence Assay Market
Figure 11 Growing Prevalence of Chronic Diseases to Drive the Growth of the Immunofluorescence Assay Market During the Forecast Period
Figure 12 Developing Markets to Register Higher Growth in the Forecast Period (2018–2023)
Figure 13 The US Accounted for the Largest Share of the Immunofluorescence Assay Market in 2017
Figure 14 North America to Dominate the Immunofluorescence Assay Market During the Forecast Period
Figure 15 The Reagents Segment Will Continue to Dominate the Immunofluorescence Assay Market in 2023
Figure 16 Immunofluorescence Assay Market: Drivers, Restraints, Opportunities, and Challenges
Figure 17 Cancer Prevalence and Mortality Rate, By Country, 2012
Figure 18 Pharmaceutical R&D Expenditure, By Geography, 2000 vs 2010 vs 2015
Figure 19 Global Healthcare Expenditure Per Capita, 2000 vs 2010 vs 2014
Figure 20 Reagents to Dominate the Immunofluorescence Assay Market During the Forecast Period
Figure 21 Indirect Immunofluorescence Segment to Continue to Dominate the Immunofluorescence Assay Market Till 2023
Figure 22 Cancer Segment Dominated the Immunofluorescence Assay Market in 2017
Figure 23 Pharmaceutical & Biotechnology Companies Will Continue to Dominate the Immunofluorescence Assay Market in 2023
Figure 24 Immunofluorescence Assay Market: Geographic Growth Opportunities
Figure 25 North America: Immunofluorescence Assay Market Snapshot
Figure 26 Asia Pacific: Immunofluorescence Assay Market Snapshot
Figure 27 Key Developments, 2013–2017
Figure 28 Thermo Fisher: Company Snapshot (2016)
Figure 29 Abcam: Company Snapshot (2017)
Figure 30 Bio-Rad: Company Snapshot (2016)
Figure 31 Perkinelmer: Company Snapshot (2016)
Figure 32 Merck Millipore: Company Snapshot (2016)
Figure 33 Werfen Company: Company Snapshot (2016)
Figure 34 Danaher Corporation: Company Snapshot (2016)



【レポートのキーワード】

免疫蛍光測定アッセイ、試薬、一次抗体、二次抗体、キット、画像装置、顕微鏡、疾患、癌治療、医療機器

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 免疫蛍光測定アッセイの世界市場予測(~2023年):試薬、一次抗体、二次抗体、キット、画像装置、顕微鏡(Immunofluorescence Assay Market by Product (Reagent, Primary & Secondary Antibody, Kit, Imaging Equipment, Immunofluorescence Microscopy), Type (Direct, Indirect), Disease (Cancer, Cardiovascular, Infectious Disease) & End User - Global Forecast to 2023)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆